Financials • Specialty Insurers
$0.36 ▼ +0.00
(-0.47%)
MKT CAP: $64.9M • VOL: 719.4K
52W L $0 52W H $2
ROARABLE / RQD
D- • 42/100
PIOTROSKI
4 / 9
SLQT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.53B | $1.32B | $1.00B |
| YoY Revenue Growth % | +15.5% | +31.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $68.5M | $64.5M | $11.6M |
| Operating Margin % | 4.5% | 4.9% | 1.2% |
| Net Income (GAAP) | $47.6M | -$34.1M | -$58.5M |
| EBITDA (Normalized) | $70.3M | $67.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$11.7M | $15.2M | -$19.4M |
| Capital Expenditures (CapEx) | $2.2M | $3.4M | — |
| Free Cash Flow (FCF) | -$13.9M | $11.9M | -$19.4M |
| FCF Margin % | -0.9% | 0.9% | -1.9% |
| Return on Invested Capital (ROIC %) | 7.4% | 5.1% | — |
| Cash & Short-Term Equivalents | $18.3M | $7.3M | — |
| Total Debt (Short + Long Term) | $385.7M | $684.3M | — |
| Total Stockholders' Equity | $359.7M | $326.0M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR SLQT.